GlobeNewsWire
13 Oct 2025, 12:15 UTC · 50w ago
Verdict
Headline takes no side. We score ASPI +1.00 across four claims — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
ASP Isotopes entered into its largest-ever supply contract for enriched silicon-28 with a U.S. customer, with deliveries starting in Q1 2026.
More positive than 93% of claims this week
The company acquired a Florida-based radiopharmacy, marking the first U.S. expansion of its PET Labs subsidiary.
So whatThis expands the company's geographic footprint and is explicitly expected to be accretive to 2026 revenues, EBITDA, and EPS.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 79% of claims this week
PET Labs has signed a non-binding term sheet for another U.S. acquisition and is in discussions with multiple other radiopharmacies.
More positive than 67% of claims this week
The acquired Florida facility currently offers only SPECT services, with PET services expected to begin in 2027.
More positive than 46% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company announced its largest enriched silicon-28 contract to date and a strategic acquisition expected to be accretive to 2026 revenues and EPS.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−74.3%
Price is moving against the score
$2.60 vs $10.13 close before publication (Oct 10) · not market-adjusted
ASPI chart →
